Dyclone and Bone marrow depression - a phase IV clinical study of FDA data

Summary:

We study 2,161 people who take Dyclone (dyclonine hydrochloride) or have Bone marrow depression. No report of Bone marrow depression is found in people who take Dyclone.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Dyclone?

Dyclone has active ingredients of dyclonine hydrochloride. eHealthMe is studying from 186 Dyclone users. Check the latest studies of Dyclone.

What is Bone Marrow Depression?

Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells) is found to be associated with 350 drugs and 465 conditions by eHealthMe. Check the latest studies of Bone marrow depression.

On Jul, 23, 2026

No report is found.

Do you take Dyclone and have Bone marrow depression?

- Check whether Bone marrow depression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dyclone:

Dyclone (186 reports)

Browse all side effects of Dyclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone marrow depression:

Bone marrow depression

Browse all the conditions that are associated with Bone marrow depression:

Bone marrow depression

How the study uses the data?

The study uses data from the FDA. It is based on dyclonine hydrochloride (the active ingredients of Dyclone) and Dyclone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.